Controlled SOP, validation and evidence work
A concrete GxP process is defined, relevant sources can be bounded and experts remain accountable for review and decision.
All industries →
BIOTECH · ORGANISATIONAL FIT
AI for biotech quality teams: where traqx fits.
traqx fits a biotech quality team when the concrete work object is genuinely GxP-relevant and controlled sources are needed for SOP, validation, qualification or audit groundwork. Not every biotech activity is GxP; exploratory research, drug discovery and scientific decisions are not the product fit described here.
THREE CONCRETE SITUATIONS
How traqx prepares groundwork in biotech quality work.
Each situation stays within the scope defined by the team. traqx connects controlled inputs to a reviewable result without classifying research as GxP by default.
Frame requirements for transferring a biological manufacturing process
CONTROLLED INPUTS
Defined transfer work package for a biological manufacturing process, current process description, approved site policies, selected external requirements and a documented scope assumption.
AGENT TASK
Compliance Agent · Maps statements to the approved sources and marks missing evidence and unresolved scope questions.
REVIEWABLE RESULT
Evidenced statements, a gap list and clearly identified questions about the intended scope.
HUMAN / SYSTEM BOUNDARY
The biotech team decides which requirements apply to the transfer work package and its GxP scope; traqx does not classify that scope autonomously.
Move a development instruction into a defined GxP-relevant operating step
CONTROLLED INPUTS
Existing development or work instruction, the team-defined move into GxP-relevant operations, approved policy and current template.
AGENT TASK
SOP Agent · Prepares a source-bound, traceable revision for the new process boundary.
REVIEWABLE RESULT
Word file with tracked changes, source and rationale comments, and an updated version history.
HUMAN / SYSTEM BOUNDARY
Subject-matter experts define the scope and transition and own review and release; traqx does not pull research into GxP scope itself.
Document newly added equipment or a computer system in the defined scope
CONTROLLED INPUTS
Newly added equipment or computer system in the team's defined GxP scope, approved intended use, equipment or system description, process interfaces and commissioning risk assumptions.
AGENT TASK
Validation Agent · Prepares requirements, risks, tests and potential traces from the controlled foundations.
REVIEWABLE RESULT
Draft requirements and risks, test and traceability candidates, and clearly marked gaps.
HUMAN / SYSTEM BOUNDARY
The validation expert assesses and decides; early research outside the defined scope remains untouched.
CONTROLLED WORKING MODEL
Define the scope first. Then prepare controlled groundwork.
The actual GxP process bounds sources, method and review. The industry label alone is not enough.
- 01 · SCOPE
Bound the GxP-relevant work object
The team determines which process, sources and internal requirements genuinely belong in the controlled scope.
Result · deliberate scope boundary - 02 · GENERATE
Prepare research, draft and update
traqx works inside the defined source room and creates reviewable suggestions instead of drawing on open-web context.
Result · bounded groundwork - 03 · VERIFY
Keep source, status and open points visible
Evidence passages and gaps stay on the work object; unsupported points are not treated as finished decisions.
Result · reviewable work state - 04 · REVIEW
Let subject-matter experts review and decide
Quality and functional experts correct, accept or reject. The existing approval path remains in force.
Result · human decision
FIT / BOUNDARY
A fit for GxP-relevant quality work. Not automatically for all biotech work.
The organization defines the real process and regulatory context; traqx does not infer it from the industry.
OPTIONAL PROCESS EXTENSION: A separately bookable GxP module is only added when a recurring process also needs a preconfigured method, templates, defined work objects and a review path. When a GxP module is added →
Drug discovery, laboratory informatics or research decision
traqx is neither a scientific decision platform nor a LIMS here, and it does not turn exploratory research into blanket GxP work.
PRODUCT EVIDENCE, NOT A MATURITY CLAIM
Inspect the working model without a biotech-specific promise.
traqx is EU-hosted and works in controlled source rooms; customer documents stay within the agreed tenant and hosting scope and are not used for model training. Experts review and decide. The product dossiers show real system views with synthetic demo data—not biotech customer outcomes.
Trust Architecture → View product dossiers →VISIBLE PRIMARY SOURCES
GMP sources apply only when GMP manufacturing is actually in scope.
- European Commission · EudraLex Volume 4
The official collection of EU GMP guidelines is relevant when the concrete biotech process falls within a GMP manufacturing context. The industry label alone does not establish that link.
- EU GMP Chapter 4 · Documentation
Chapter 4 frames documentation inside the GMP context. The source is not extended here to exploratory research or scientific decision work.
FAQ
Biotech fit starts with the scope question.
Is traqx a fit for a biotech quality team—and does the work need to be GxP-relevant?
traqx fits a biotech quality team when the concrete work object is genuinely GxP-relevant and controlled sources are needed for SOP, validation, qualification or audit groundwork. Not every biotech activity is GxP; exploratory research, drug discovery and scientific decisions are not the product fit described here.
Who decides whether a biotech work object is GxP-relevant?
The customer frames the actual process against the applicable regulatory and internal context. traqx supports controlled work inside the defined scope but makes no legal or subject-matter GxP classification.
How does traqx prevent research documents from entering GxP scope without review?
The team defines the work object, process boundary and approved sources in advance. traqx works only inside that controlled scope and identifies open scope questions instead of classifying research as GxP-relevant itself.
Is traqx a drug-discovery or laboratory platform?
No. This page promises neither drug-discovery functions nor laboratory informatics or scientific decision support. The fit is controlled quality and document work inside the actual GxP scope.
FRAME THE BIOTECH SCOPE
Start with the concrete GxP work object.
Together, we check scope, source room, agent task, review and system boundary on one real work case.
Book a meeting →Other industries: All industries · Pharmaceuticals · Medical devices · CDMO / CMO · Contract research organizations